Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 22 for “"Computational Drug Design"”.

  1. Overcoming the Curse of Missing and Noisy Data in Computational Drug Design

    … (ML) has enjoyed great success in chemistry and drug design, from designing synthetic pathways to drug screening, to biomolecular property predictions, etc.. However, ML model's generalizability and robustness require high-quality training data, which is often difficult to obtain, especially when …

    mcmaster Repository record for Overcoming the Curse of Missing and Noisy Data in Computational Drug Design (opens in a new tab)

  2. Markov chains under combinatorial constraints: analysis and synthesis

    … of applications, such as urban road traffic, computational drug design, and the spread of disease. In many such applications, there are existing constraints on the structure of the underlying network dictating which transitions are possible, and which are not. In this thesis, the influence of …

    manitoba Repository record for Markov chains under combinatorial constraints: analysis and synthesis (opens in a new tab)

  3. Lbpi: A Web Interface For The Identification of Allosteric Ligand Binding Sites

    … ligand binding site identification in potential drug targets is an important step for computational drug design. Ligand binding specificity analysis (LIBSA) is one of the protocols that utilize filtering algorithms to assess the propensity of a site on a target structure or structures to bind a …

    uthsc Repository record for Lbpi: A Web Interface For The Identification of Allosteric Ligand Binding Sites (opens in a new tab)

  4. Lbpi: A Web Interface For The Identification of Allosteric Ligand Binding Sites

    … ligand binding site identification in potential drug targets is an important step for computational drug design. Ligand binding specificity analysis (LIBSA) is one of the protocols that utilizes filtering algorithms to assess the propensity of a site on a target structure or structures to bind a …

    uthsc Repository record for Lbpi: A Web Interface For The Identification of Allosteric Ligand Binding Sites (opens in a new tab)

  5. AI Enabled Drug Design and Side Effect Prediction Powered by Multi-Objective Evolutionary Algorithms & Transformer Models

    … large search space and conflicting objectives, drug design and discovery is a difficult problem for which new machine learning (ML) approaches are required. Here, the problem is to invent a method by which new, therapeutically useful, compounds can be discovered; and to simultaneously avoid …

    brock Repository record for AI Enabled Drug Design and Side Effect Prediction Powered by Multi-Objective Evolutionary Algorithms & Transformer Models (opens in a new tab)

  6. Computation Schemes for Transfer Operators

    … statistics, the prediction of stock prices, and computational drug design. The first part of this doctoral thesis is a purely theoretical investigation of the transfer operator. Characterizations of transfer operators and adjoint transfer operators are revealed. It is shown that Markov operators …

    fu-berlin Repository record for Computation Schemes for Transfer Operators (opens in a new tab)

  7. Design, synthesis and biological evaluation of retinoid and non-retinoid mimetics of fenretinide as chemotherapeutic agents

    … and young adults. The mechanism of action of the drug is not known. The major disadvantage to fenretinide as a treatment for cancer is its poor in vivo efficacy due to poor oral bioavailability, requiring the patient to take many tablets per day regularly in order to achieve an adequate plasma …

    whiterose Download PDF for Design, synthesis and biological evaluation of retinoid and non-retinoid mimetics of fenretinide as chemotherapeutic agents (opens in a new tab)

  8. Advancing Drug Discovery with Structural and Representation Learning of Biological Systems

    … the profound limitations of conventional drug discovery methods, which are inherently protracted and resource-intensive. A robust, accelerated response framework demands the sophisticated deployment of Artificial Intelligence (AI) and Machine Learning (ML) across the entire therapeutic …

    ucf Repository record for Advancing Drug Discovery with Structural and Representation Learning of Biological Systems (opens in a new tab)

  9. Equilibrium free energies from nonequilibrium simulations: Improving convergence by reducing dissipation

    … energy differences is an important problem in computational thermodynamics, with applications to studies of ligand binding, phase coexistence and phase equilibrium, solvation of small molecules, and computational drug design, among others. Recent advances in nonequilibrium statistical …

    maryland Repository record for Equilibrium free energies from nonequilibrium simulations: Improving convergence by reducing dissipation (opens in a new tab)

  10. Investigations on Key Principles of PTP1B Selectivity

    … Tyrosine Phosphatase 1B (PTP1B) is a validated drug target for the treatment of diabetes type 2 and obesity. Until now, development of suitable modulators has been hampered by the polarity of the binding site and related bioavailability issues of the molecules. The design of selective inhibitors …

    fu-berlin Repository record for Investigations on Key Principles of PTP1B Selectivity (opens in a new tab)

  11. Absolute binding enthalpy calculations using molecular dynamics simulations

    <p>Computers play an essential role in drug discovery as advancements in technology, hardware, and algorithms have allowed for improved simulations of biomolecules. The field of drug discovery stands to benefit significantly from these developments. Currently, many innovative approaches to studying …

    oxford Repository record for Absolute binding enthalpy calculations using molecular dynamics simulations (opens in a new tab)

  12. Structure-based prediction of protein-protein interaction sites

    … methods, and identifying and prioritizing drug targets in computational drug design. Because of the difficulty and the high cost of experimental characterization of interface residues, there is an urgent need for computational methods for reliable predicting protein-protein interface …

    iastate Repository record for Structure-based prediction of protein-protein interaction sites (opens in a new tab)

  13. Quantum mechanical methods for structure-based drug design

    … mechanical (QM) methods are becoming popular in computational drug design and development mainly because high accuracy is required to estimate (relative) binding affinities. For low- to medium-throughput in silico screening, (e.g., scoring and prioritizing a series of inhibitors sharing the same …

    zurich

  14. Kernel Methods in Computer-Aided Constructive Drug Design

    A drug is typically a small molecule that interacts with the binding site of some target protein. Drug design involves the optimization of this interaction so that the drug effectively binds with the target protein while not binding with other proteins (an event that could produce dangerous side …

    waterloo Repository record for Kernel Methods in Computer-Aided Constructive Drug Design (opens in a new tab)

  15. In silico structure-based optimisation of pyrrolidine carboxamides as Mycobacterium tuberculosis enoyl-ACP reductase inhibitors

    … rates and recent emergence of extremely drug resistant forms of Mycobacterium tuberculosis pose a significant challenge for global health. The NADH- dependent enoyl-ACP-reductase InhA of the type II mycobacterial fatty acid biosynthesis pathway is a well-validated target for inhibiting …

    wurz-thes Repository record for In silico structure-based optimisation of pyrrolidine carboxamides as Mycobacterium tuberculosis enoyl-ACP reductase inhibitors (opens in a new tab)

  16. Elucidating the antimycobacterial mechanisms of ciprofloxacin and decoquinate derivative RMB041 on Mycobacterium tuberculosis using metabolomics

    … amongst others: the rapid development of anti-TB drug resistance, poor patient adherence, and inadequate treatment regimens. Subsequently, a better understanding of the mechanisms of action (MoA) of the new anti- TB drugs, as well as the possible mechanisms of resistance (MoR) of Mtb to these, is …

    nwu-za Repository record for Elucidating the antimycobacterial mechanisms of ciprofloxacin and decoquinate derivative RMB041 on Mycobacterium tuberculosis using metabolomics (opens in a new tab)

  17. Computational modeling of the peripheral membrane binding protein annexin A2

    Computational methods including molecular dynamics and molecular docking were utilized to investigate multiple facets of the peripheral membrane binding protein, Annexin A2 (A2). The combined works are presented here as five independent studies. All atomic molecular dynamics simulations were used …

    ecu Repository record for Computational modeling of the peripheral membrane binding protein annexin A2 (opens in a new tab)

  18. Generative Bayesian Optimization for Structured Design

    … as black-box optimization. For example, in drug discovery one might seek to design a small molecule that maximizes a real-valued objective function, such as predicted therapeutic activity against a target pathogen. Such objectives lack closed-form expressions and may require costly …

    penn Repository record for Generative Bayesian Optimization for Structured Design (opens in a new tab)

  19. Computationally driven design of small-molecule reversible covalent inhibitors for targeted therapeutics

    … irreversible inhibitors. However, their rational design remains challenging due to the complex interplay between binding affinity, covalent kinetics, and resistance evolution. This review presents an integrated computational framework for RCI discovery, combining cheminformatics and machine …

    laurentian Repository record for Computationally driven design of small-molecule reversible covalent inhibitors for targeted therapeutics (opens in a new tab)

  20. Computational methods for assessing drug-target residence times in bacterial enoyl-ACP reductases and predicting small-molecule permeability for the \(Mycobacterium\) \(tuberculosis\) cell wall

    \textbf{Molecular Determinants of Drug-Target Residence Times of Bacterial Enoyl-ACP Reductases.} Whereas optimization processes of early drug discovery campaigns are often affinity-driven, the drug-target residence time $t_R$ should also be considered due to an often strong correlation with …

    wurz-thes Repository record for Computational methods for assessing drug-target residence times in bacterial enoyl-ACP reductases and predicting small-molecule permeability for the \(Mycobacterium\) \(tuberculosis\) cell wall (opens in a new tab)

Page 1 of 2